Innovative Siemens system provides new views of blood vessels, tissue, and organs

SIEMENSA new milestone on two levels: Siemens recently introduced the Axiom Artis dBA Twin biplanar radiography system, its latest imaging system for universal angiography and neuroradiology. Together with the new flat detector technology and syngo DynaCT software, the system delivers unique acquisitions thanks to its extremely high contrast and soft tissue differentiation.

The new Axiom Artis dBA Twin radiography system offers flexibility across the entire application spectrum, from neuroradiological and abdominal examinations, to pediatric applications requiring low dose. The unit is equipped with two 30 x 40 flat detectors. The modern biplanar flat detector technology delivers excellent detail resolution that supports physician decision-making in diagnostics and interventions. The biplanar system enables fast display of the anatomy in two planes, providing accurate work through simultaneous imaging. The system also supports the physician's workflow through programmable detector positioning and intelligent collision protection.

Angiography and syngo DynaCTAngiography and syngo DynaCT
With the optional syngo DynaCT, Axiom Artis dBA Twin achieves soft tissue differentiation comparable to computed tomography (CT) acquisitions. As a result, intracranial bleeding can be detected faster than ever before, and brain tissue can be displayed in greater detail than with conventional procedures. Using the latest version of syngo DynaCT, which was introduced for the first time at the RSNA (Radiological Society of North America), in critical situations physicians receive clinically-relevant results of the highest possible resolution within one minute, supporting therapy decision-making. In addition, this method is used to check therapeutic measures. The advantage: the patient is not subjected to an additional computed tomography or magnetic resonance imaging (MRI) examination.

Innovative applications for neuroradiology as well as for abdominal and oncological interventions have been created with this technology. Through the continuous development and enhancement of syngo DynaCT, Siemens again confirms its leadership role in the industry. Last month, Siemens celebrated its 100th US syngo DynaCT installation at the Swedish Medical Center in Seattle, USA. This milestone attests not only to the popularity of this trendsetting technology, but also to its far-reaching implications for health care as a whole. To date, the application has been installed some 260 times worldwide.

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics – such as Diagnostic Products Corporation and Bayer Diagnostics – mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting http://www.siemens.com/medical

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...